Begin main content

Reports

We found 6590 result(s)

Recombinant human growth hormone for Turner syndrome: systematic review and economic evaluation

Last Updated: December 21, 2007
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Technology and Condition Recombinant human growth hormone (rhGH) for treatment of Turner syndrome (TS). Issue Given the high cost of rhGH treatment and the evolving evidence base for its clinical effect in patients with TS, policy makers need evidence
to inform reimbursement decisions about rhGH. Methods and Results A system...

Rivastigmine (Exelon Patch)

Last Updated: December 21, 2007
Result type: Reports
Product Line: Common Drug Review
Generic Name: Rivastigmine
Indications: Dementia (Alzheimer's type)

  • Brand Name: Exelon Patch
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: S0123
  • Project Status: Complete
  • Submission Type: New

Overview of Thiazide Diuretics as First-Line Treatment for Hypertension

Last Updated: December 21, 2007
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Technology and Condition Thiazide diuretics (TZD) chlorthalidone, hydrochlorothiazide, indapamide, and metolazone for primary hypertension (at least 140 mm Hg systolic or 90 mm Hg diastolic blood pressure). Issue Despite their demonstrated clinical effectiveness and low cost, the rate of first-line TZD use in newly treated hypertensive patien...

Thiazide Diuretics as First-Line Treatment for Hypertension: Meta-analysis and Economic Evaluation

Last Updated: December 21, 2007
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Technology and Condition Thiazide diuretics (TZD) chlorthalidone, hydrochlorothiazide, indapamide, and metolazone for primary hypertension (at least 140 mm Hg systolic or 90 mm Hg diastolic blood pressure). Issue Despite their demonstrated clinical effectiveness and low cost, the rate of first-line TZD use in newly treated hypertensive patien...

Overview of Recombinant Human Growth Hormone for Treatment of Turner Syndrome: Systematic Review and Economic Evaluation

Last Updated: December 21, 2007
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Technology and Condition Recombinant human growth hormone (rhGH) for treatment of Turner syndrome (TS). Issue Given the high cost of rhGH treatment and the evolving evidence base for its clinical effect in patients with TS, policy makers need evidence to inform reimbursement decisions about rhGH. Methods and Results A systematic review was ...

Sitagliptin phosphate (Januvia)

Last Updated: December 20, 2007
Result type: Reports
Product Line: Common Drug Review
Generic Name: Sitagliptin phosphate
Indications: Diabetes mellitus (Type 2)

  • Brand Name: Januvia
  • Manufacturer: Merck Frosst Canada Ltd.
  • Project Number: S0122
  • Project Status: Complete
  • Submission Type: New